While semaglutide and tirzepatide are GLP-1 receptor agonists that suppress appetite by mimicking gut hormones, tesofensine is a triple monoamine reuptake inhibitor that blocks the reabsorption of dopamine, serotonin, and noradrenaline in the brain, which reduces appetite
Rybelsus is now the first and only oral glucagon-like peptide 1 receptor agonist (GLP-1 RA), mimicking a natural hormone in the body that helps regulate blood sugar, appetite, and digestion, available in the EU for type 2 diabetes with a proven cardiovascular benefit
Scenario 3: repeated early dosing over multiple weeks This is the scenario that actually requires caution
This helps your doctor document medical necessity if they decide to submit a prior authorization
Most patients achieve a 10% reduction in body weight within the first 6 months, with many reaching 15-20% total body weight loss after one year of consistent use